1. Home
  2. MTSI vs GH Comparison

MTSI vs GH Comparison

Compare MTSI & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MACOM Technology Solutions Holdings Inc.

MTSI

MACOM Technology Solutions Holdings Inc.

HOLD

Current Price

$239.33

Market Cap

16.4B

Sector

Technology

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$101.14

Market Cap

14.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTSI
GH
Founded
1950
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.4B
14.8B
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
MTSI
GH
Price
$239.33
$101.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
21
Target Price
$232.60
$102.81
AVG Volume (30 Days)
1.5M
2.0M
Earning Date
02-05-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.17
N/A
Revenue
$1,020,748,000.00
$902,569,000.00
Revenue This Year
$18.69
$35.23
Revenue Next Year
$13.24
$27.38
P/E Ratio
$109.32
N/A
Revenue Growth
29.12
30.38
52 Week Low
$84.00
$34.88
52 Week High
$241.62
$120.74

Technical Indicators

Market Signals
Indicator
MTSI
GH
Relative Strength Index (RSI) 66.42 40.73
Support Level $225.98 $100.26
Resistance Level $241.62 $107.69
Average True Range (ATR) 13.23 6.19
MACD -0.10 -1.38
Stochastic Oscillator 88.15 12.10

Price Performance

Historical Comparison
MTSI
GH

About MTSI MACOM Technology Solutions Holdings Inc.

MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: